TY - JOUR
T1 - Isolation and structural identification of a direct-acting mutagen derived from N-nitroso-N-methylpentylamine and Fenton's reagent with copper ion
AU - Miura, Motofumi
AU - Inami, Keiko
AU - Yoshida, Masafumi
AU - Yamaguchi, Kentaro
AU - Mashino, Tadahiko
AU - Mochizuki, Masataka
N1 - Funding Information:
This work was supported in part by a Grant-in-Aid for the Ministry of Education, Culture, Sports, Sciences and Technology of Japan.
PY - 2011/9/15
Y1 - 2011/9/15
N2 - N-Nitrosodialkylamines show their mutagenicity by forming α-hydroxynitrosamines in the presence of rat S9 mix in the Ames assay. The hydroxyl radical derived from Fe 2+-H 2O 2 (Fenton's reagent) with Cu 2+ activates N-nitrosamines, with an alkyl chain longer than a propyl constituent, to a direct-acting mutagen. The reactivity of Fe 2+-Cu 2+-H 2O 2 on nitrosamines in relation to their metabolic activation is not fully characterized. Here, we report the identification of the direct-acting mutagen derived from N-nitroso-N-methylpentylamine (NMPe) in the presence of Fe 2+, Cu 2+, H 2O 2 and nitric oxide (NO), which is a product of nitrosamine metabolism. A dichloromethane extract of the NMPe reaction mixtures was fractionated by silica gel column chromatography several times and by a preparative high performance liquid chromatography (HPLC); we obtained white crystals as a product. The direct-acting mutagen that was isolated was provisionally identified as 5-ethyl-5-nitro-1-pyrazoline 1-oxide by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy and X-ray crystallography. To confirm the structure of the mutagen, the authentic compound was synthesized from 2-nitrobutene and diazomethane, followed by N-oxidation with m-chloroperoxybenzoic acid. The 1H NMR spectral data from the direct-acting mutagen that was synthesized was identical to the data from the isolated mutagen. Furthermore, the authentic 5-ethyl-5-nitro-1-pyrazoline 1-oxide was mutagenic in Salmonella typhimurium TA1535. The results showed that 5-ethyl-5-nitro-1-pyrazoline 1-oxide was a direct-acting mutagen derived from the reaction of NMPe and Fe 2+-Cu 2+-H 2O 2-NO.
AB - N-Nitrosodialkylamines show their mutagenicity by forming α-hydroxynitrosamines in the presence of rat S9 mix in the Ames assay. The hydroxyl radical derived from Fe 2+-H 2O 2 (Fenton's reagent) with Cu 2+ activates N-nitrosamines, with an alkyl chain longer than a propyl constituent, to a direct-acting mutagen. The reactivity of Fe 2+-Cu 2+-H 2O 2 on nitrosamines in relation to their metabolic activation is not fully characterized. Here, we report the identification of the direct-acting mutagen derived from N-nitroso-N-methylpentylamine (NMPe) in the presence of Fe 2+, Cu 2+, H 2O 2 and nitric oxide (NO), which is a product of nitrosamine metabolism. A dichloromethane extract of the NMPe reaction mixtures was fractionated by silica gel column chromatography several times and by a preparative high performance liquid chromatography (HPLC); we obtained white crystals as a product. The direct-acting mutagen that was isolated was provisionally identified as 5-ethyl-5-nitro-1-pyrazoline 1-oxide by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy and X-ray crystallography. To confirm the structure of the mutagen, the authentic compound was synthesized from 2-nitrobutene and diazomethane, followed by N-oxidation with m-chloroperoxybenzoic acid. The 1H NMR spectral data from the direct-acting mutagen that was synthesized was identical to the data from the isolated mutagen. Furthermore, the authentic 5-ethyl-5-nitro-1-pyrazoline 1-oxide was mutagenic in Salmonella typhimurium TA1535. The results showed that 5-ethyl-5-nitro-1-pyrazoline 1-oxide was a direct-acting mutagen derived from the reaction of NMPe and Fe 2+-Cu 2+-H 2O 2-NO.
KW - Fenton's reagent
KW - Hydroxyl radical
KW - Metabolic activation
KW - N-Nitrosodialkylamine
KW - Nitric oxide
KW - Pyrazoline
UR - http://www.scopus.com/inward/record.url?scp=80052580696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052580696&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2011.07.012
DO - 10.1016/j.bmc.2011.07.012
M3 - Article
C2 - 21873073
AN - SCOPUS:80052580696
SN - 0968-0896
VL - 19
SP - 5693
EP - 5697
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 18
ER -